Abstract
Pandemic COVID caused significant increase in digital healthcare technologies (DHT) utilisation. Since a potential hindrance to their further adoption may the healthcare professionals’ receptivity, pharmacists’ knowledge and attitudes towards the technologies were investigated in Serbia. Cross sectional study was conducted through a purposefully created and voluntarily and anonymously self-reported online survey. Out of 119 participants, 87% were pharmacists working in a pharmacy, 7% in teaching, science and other branches, while 6% were pharmaceutical technicians. Uninformed or incorrect was on average 86% of the participants about digital medicines and 90% about digital therapeutics. “Natural cycles” was recognized by 25% of the participants. However, the average of 66% thought DHT could help healthcare professionals and patients in health preservation, diagnosis and therapy, while 25% were undecided. This could indicate a lack of pharmacists’ exposure to information, rather than the previously described mistrust towards DHT. Only 13% of the participants were uninterested to learn more about the various aspects of digital pharmacy, which may support the hypothesis. A significantly higher number of participants, 66%, was familiar with telemedicine. Despite its expansion caused by the pandemic, 74% of the participants labelled direct contact with patients as “very important”. This may impede telemedicine application to pharmaceutical healthcare, notwithstanding that 47% wanted to learn more about telemedicine. The results indicated potential openness towards the utilisation, as well as the lack of education on DHT, with the exception of telemedicine.
References
Silva R.d.O.S, de Araújo D.C.S.A, dos Santos Menezes P.W. Digital pharmacists: the new wave in pharmacy practice and education. Int J Clin Pharm 2022.
Rijcken C. Pharmaceutical care in digital revolution. Insights Towards Circular Innovation. Academic Press 2019.
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).